1. Home
  2. ATRC vs DQ Comparison

ATRC vs DQ Comparison

Compare ATRC & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • DQ
  • Stock Information
  • Founded
  • ATRC 2000
  • DQ 2006
  • Country
  • ATRC United States
  • DQ China
  • Employees
  • ATRC N/A
  • DQ N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • DQ Semiconductors
  • Sector
  • ATRC Health Care
  • DQ Technology
  • Exchange
  • ATRC Nasdaq
  • DQ Nasdaq
  • Market Cap
  • ATRC 1.5B
  • DQ 1.4B
  • IPO Year
  • ATRC 2005
  • DQ 2010
  • Fundamental
  • Price
  • ATRC $34.57
  • DQ $13.36
  • Analyst Decision
  • ATRC Strong Buy
  • DQ Hold
  • Analyst Count
  • ATRC 10
  • DQ 6
  • Target Price
  • ATRC $49.60
  • DQ $20.31
  • AVG Volume (30 Days)
  • ATRC 581.4K
  • DQ 694.1K
  • Earning Date
  • ATRC 04-29-2025
  • DQ 04-29-2025
  • Dividend Yield
  • ATRC N/A
  • DQ N/A
  • EPS Growth
  • ATRC N/A
  • DQ N/A
  • EPS
  • ATRC N/A
  • DQ N/A
  • Revenue
  • ATRC $480,076,000.00
  • DQ $737,683,000.00
  • Revenue This Year
  • ATRC $14.63
  • DQ N/A
  • Revenue Next Year
  • ATRC $12.62
  • DQ $90.46
  • P/E Ratio
  • ATRC N/A
  • DQ N/A
  • Revenue Growth
  • ATRC 15.79
  • DQ N/A
  • 52 Week Low
  • ATRC $18.94
  • DQ $12.41
  • 52 Week High
  • ATRC $43.11
  • DQ $30.85
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 60.03
  • DQ 41.53
  • Support Level
  • ATRC $31.95
  • DQ $13.51
  • Resistance Level
  • ATRC $34.08
  • DQ $14.11
  • Average True Range (ATR)
  • ATRC 1.14
  • DQ 0.61
  • MACD
  • ATRC 0.31
  • DQ 0.04
  • Stochastic Oscillator
  • ATRC 94.66
  • DQ 4.56

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: